Low-frequency RNA-Seq exon junction(s) not annotated.
Gene model reviewed during 5.47
3.0 (northern blot)
Click to get a list of regulatory features (enhancers, TFBS, etc.) and gene disruptions (point mutations, indels, etc.) within or overlapping Dmel\myo using the Feature Mapper tool.
myo transcripts are detected throughout development on northern blots with peaks in 0-2hr embryos, 12-24hr embryos, and in adults. They are uniformly distributed in preblastoderm embryos with an elevated level in the pole plasm. By stage 6, they are observed in the pole cells and reduced levels are observed in the rest of the embryo. Zygotic expression of myo is first observed at stage 11 in glial precursors and it continues to be expressed in glia until stage 15. From stage 15 on expression is detected in the somatic, visceral, and heart musculature. In third instar larvae, expression is observed in a subset of cells in the brain and ventral nerve cord that are thought to be glia.
GBrowse - Visual display of RNA-Seq signalsView Dmel\myo in GBrowse 2
Please Note This section lists cDNAs and ESTs that fall within the genomic extent of the gene model, which may include cDNAs and ESTs of genes within introns, or of overlapping genes. Please see GBrowse for alignment of the cDNAs and ESTs to the gene model.
For each fully sequenced cDNA the DGRC maintains various forms of the cDNA (e.g tagged or untagged) in several different host vectors for subsequent cloning and expression in Drosophila and Drosophila cell lines.